IMRX
Immuneering Corp
4.30$
-0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -1,997.8% | – | – | – | – | – | -4,571.6% | -15,722.8% | |
| – | – | – | – | – | 12.9% | – | – | – | – | – | 25.4% | 96.9% | |
| – | – | – | – | – | 237.5% | – | – | – | – | – | 451.0% | 1,761.6% | |
| – | – | – | – | – | 232.9% | – | – | – | – | – | -129.1% | -1,498.8% | |
| – | – | – | – | – | 1.3% | – | – | – | – | – | 7.6% | 66.1% | |
| – | – | – | – | – | 755.9% | – | – | – | – | – | 2,903.4% | -39,150.8% | |
| – | – | – | – | – | – | – | – | – | – | – | 47,186.9% | – | |
| – | – | – | – | – | -5.6% | – | – | – | – | – | 6.8% | 59,020.7% | |
| – | – | – | – | – | -1,247.5% | – | – | – | – | – | -1,661.4% | 4,147.1% | |
| – | – | – | – | – | -1,999.1% | – | – | – | – | – | -4,579.1% | -15,788.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.